29 275

Cited 90 times in

Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.

Authors
Park, HJ; Lee, PH; Ahn, YW; Choi, YJ; Lee, G; Lee, DY; Chung, ES; Jin, BK
Citation
The European journal of neuroscience, 26(1):79-89, 2007
Journal Title
The European journal of neuroscience
ISSN
0953-816X1460-9568
Abstract
Epidemiological studies have reported that smoking is associated with a lower incidence of Parkinson's disease (PD), leading to theories that smoking in general and nicotine in particular might be neuroprotective. Recent studies suggested cholinergic anti-inflammatory pathway-regulating microglial activation through alpha7 nicotinic receptors. In the present study, we used lipopolysaccharide (LPS)-induced in vitro and in vivo inflammation models to investigate whether nicotine has a protective effect on the dopaminergic system through an anti-inflammatory mechanism. Nicotine pretreatment considerably decreased microglial activation with significant reduction of tumour necrosis factor (TNF)-alpha mRNA expression and TNF-alpha release induced by LPS stimulation. In co-cultures of microglia and mesencephalic neurons, nicotine pretreatment significantly decreased the loss of tyrosine hydroxylase-immunopositive (TH-ip) cells, approximately twice more than the LPS-only treatment. alpha-Bungarotoxin, an alpha7 nicotinic acetylcholine receptor subunit-selective blocker, considerably blocked the inhibitory effects of nicotine on microglial activation and TH-ip neuronal loss. Chronic nicotine pretreatment in rats showed that TH-ip neuronal loss induced by LPS stimulation in the substantia nigra was dramatically decreased, which was clearly accompanied by a reduction in the formation of TNF-alpha. The present study demonstrated that nicotine has a neuroprotective effect on dopaminergic neurons via an anti-inflammatory mechanism mediated by the modulation of microglial activation. Along with various neuroprotective effects of nicotine, the anti-inflammatory mechanism of nicotine could have a major therapeutic implication in the preventive treatment of PD.
MeSH terms
AnimalsAnimals, NewbornAnti-Inflammatory Agents*Bungarotoxins/pharmacologyCell CountCoculture TechniquesDopamine/physiology*ImmunohistochemistryLipopolysaccharides/pharmacologyMesencephalon/cytologyMesencephalon/drug effectsMesencephalon/pathologyMicroglia/drug effectsNeurons/drug effects*Neuroprotective Agents*Nicotine/pharmacology*Nicotinic Antagonists/pharmacologyNitric Oxide/metabolismParkinson Disease/metabolismParkinson Disease/pathologyParkinson Disease/prevention & control*RatsRats, Sprague-DawleyReverse Transcriptase Polymerase Chain ReactionTumor Necrosis Factor-alpha/metabolismTyrosine 3-Monooxygenase/metabolism
DOI
10.1111/j.1460-9568.2007.05636.x
PMID
17581257
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
Journal Papers > Research Organization > BK21
Journal Papers > School of Medicine / Graduate School of Medicine > Neurosurgery
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Journal Papers > Research Organization > Institute for Medical Sciences
AJOU Authors
이필휴안영환이광정은숙진병관
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse